EUVIMED · CrossrefZeitschrift
Breast Cancer Management
ISSN 1758-1923 · Informa UK Limited
Neueste Artikel
The impact of consanguinity on women’s attitudes toward molecular testing of breast cancer in Saudi Arabia
The Utility of the Tumor Markers CA15.3, CEA, CA-125 and CA19.9 in Metastatic Breast Cancer
Effects of Major Lifestyle Factors on Breast Cancer Risk: Impact of Weight, Nutrition, Physical Activity, Alcohol and Tobacco
Direct Medical Costs for Stage-Specific Breast Cancer: A Retrospective Analysis
Current and Future Methods for Measuring Breast Density: A Brief Comparative Review
Triple-Negative Breast Cancer – The Past, Present and Future: Recent and Emerging Trends in Immunotherapy
Chemotherapy-Induced Cardiotoxicity in Breast Cancer Patients
Immediate Implant-Based Breast Reconstruction Using the TIGR ® Matrix Mesh
Management of Fatigue Following Breast Cancer Treatment
Can We Predict and Prevent Specific Sites of Metastases in Breast Cancer Patients?
Fertility Preservation in BRCA -Mutated Breast Cancer Patients
Reliability of MRI in Measuring the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients and Its Therapeutic Implications
Management of Locally Advanced and Metastatic Breast Cancer: Guidelines, Infrastructures and Low Resource Settings
Use of Complementary Therapies for Side Effect Management in Breast Cancer: Evidence and Rationale
Update from the 33rd Miami Breast Cancer Conference, FL, USA, 10–13 March 2016
Curcumin and Extracellular Matrix Proteins Synergistically Act to Inhibit the Proliferation of Breast Cancer Cells
Management and 5-Year Survival of BRCA1 -Associated Breast Cancer Patients
Exploration of Communication Gaps Among Women with Metastatic Breast Cancer, Caregivers and Oncologists
Overview of Tomosynthesis (3D Mammography) for Breast Cancer Screening
Should Bone-Targeted Agents be Standard of Care in Postmenopausal Patients with Early Breast Cancer?
Challenges in the Early Detection of Breast Cancer in Resource-Poor Settings
Breast Cancer Management with Melanie E Royce: BOLERO-4 Phase II Trial of First-Line Everolimus Plus Letrozole in ER + , HER2 - Advanced Breast Cancer
Is it Time to Relook the Management of Axilla in Post-Neoadjuvant Breast Cancer Cases in a Re-Evolving Era of Current Axillary Management?
Management and Survival of Patients with Leptomeningeal Disease from Breast Cancer: A Case Series
eHealth Solutions for Therapy Management in Oncology
Interview for Breast Cancer Management with Dr David Montgomery: Marketing Authorization for Pfizer’s Metastatic Breast Cancer Treatment, Palbociclib (Ibrance®) in Combination with Endocrine Therapy
Foreword: Message from the Editor
Multimodal Imaging for Clinical Target Volume Definition in Prone Whole-Breast Irradiation: A Single Institution Experience
Evaluation of Serum Levels of 8-Oxo-2′-Deoxyguanosine as a Prognostic Factor in Nonmetastatic Breast Cancer Patients
Hyperthermia and Radiotherapy Combination for Locoregional Recurrences of Breast Cancer: A Review
EUVIMED